{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T02:56:44Z","timestamp":1790737004687,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"20","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,16]],"date-time":"2022-11-16T00:00:00Z","timestamp":1668556800000},"content-version":"vor","delay-in-days":380,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["DTP-1522025"],"award-info":[{"award-number":["DTP-1522025"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jacc.2021.08.065","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T16:41:58Z","timestamp":1636389718000},"page":"1954-1964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Cost-Effectiveness of Lipid-Lowering Treatments in Young Adults"],"prefix":"10.1016","volume":"78","author":[{"given":"Ciaran N.","family":"Kohli-Lynch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon K.","family":"Bellows","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie","family":"Spring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruv S.","family":"Kazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J.","family":"Pletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Vittinghoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norrina B.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jacc.2021.08.065_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0154288","article-title":"Young adult exposure to cardiovascular risk factors and risk of events later in life: the Framingham Offspring Study","volume":"11","author":"Pletcher","year":"2016","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.jacc.2021.08.065_bib2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1001\/jama.2013.285122","article-title":"Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age","volume":"311","author":"Allen","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jacc.2021.08.065_bib3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.114.012477","article-title":"Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease","volume":"131","author":"Navar-Boggan","year":"2015","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jacc.2021.08.065_bib4","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1001\/jamacardio.2019.2851","article-title":"Cost-effectiveness of low-density lipoprotein cholesterol level\u2013guided statin treatment in patients with borderline cardiovascular risk","volume":"4","author":"Kohli-Lynch","year":"2019","journal-title":"JAMA Cardiol"},{"issue":"9841","key":"10.1016\/j.jacc.2021.08.065_bib5","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"issue":"20","key":"10.1016\/j.jacc.2021.08.065_bib6","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1001\/jama.2020.17108","article-title":"Behavioral counseling to promote a healthy diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"324","author":"O\u2019Connor","year":"2020","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.jacc.2021.08.065_bib7","doi-asserted-by":"crossref","first-page":"e285","DOI":"10.1016\/j.jacc.2018.11.003","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.jacc.2021.08.065_bib8","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2016.15450","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.jacc.2021.08.065_bib9","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.tcm.2019.02.004","article-title":"Statin therapy for young adults: a long-term investment worth considering","volume":"30","author":"Miedema","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.jacc.2021.08.065_bib10","series-title":"2019 Population Estimates by Age, Sex, Race and Hispanic Origin","year":"2020"},{"key":"10.1016\/j.jacc.2021.08.065_bib11","series-title":"National Health and Nutrition Examination Survey Data","year":"1999"},{"issue":"11","key":"10.1016\/j.jacc.2021.08.065_bib12","first-page":"265","article-title":"Harmonization of respiratory data from nine US population-based cohorts: the NHLBI pooled cohorts study","volume":"87","author":"Oelsner","year":"2018","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.jacc.2021.08.065_bib13","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jacc.2019.03.529","article-title":"Associations of blood pressure and cholesterol levels during young adulthood with later cardiovascular events","volume":"74","author":"Zhang","year":"2019","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.jacc.2021.08.065_bib14","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/ije\/dyy264","article-title":"Use of a pooled cohort to impute cardiovascular disease risk factors across the adult life course","volume":"48","author":"Zeki Al Hazzouri","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"11","key":"10.1016\/j.jacc.2021.08.065_bib15","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1002\/sim.2712","article-title":"Tutorial in biostatistics: competing risks and multi-state models","volume":"26","author":"Putter","year":"2007","journal-title":"Stat Med"},{"issue":"9753","key":"10.1016\/j.jacc.2021.08.065_bib16","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170\u2008000 participants in 26 randomised trials","volume":"376","year":"2010","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.jacc.2021.08.065_bib17","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1056\/NEJMoa1507652","article-title":"Coding variation in ANGPTL4, LPL, and SVEP1 and the risk of coronary disease","volume":"374","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"25","key":"10.1016\/j.jacc.2021.08.065_bib18","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1016\/j.jacc.2010.02.044","article-title":"PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses","volume":"55","author":"Benn","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2021.08.065_bib19","doi-asserted-by":"crossref","first-page":"d1672:1-9","DOI":"10.1136\/bmj.d1672","article-title":"Statin treatment for primary prevention of vascular disease: whom to treat? Cost-effectiveness analysis","volume":"342","author":"Greving","year":"2011","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jacc.2021.08.065_bib20","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1177\/2047487314525531","article-title":"What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice","volume":"21","author":"Finegold","year":"2014","journal-title":"Eur J Prev Cardiolog"},{"issue":"2","key":"10.1016\/j.jacc.2021.08.065_bib21","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1001\/jama.2015.6822","article-title":"Cost-effectiveness of 10-year risk thresholds for initiation of statin therapy for primary prevention of cardiovascular disease","volume":"314","author":"Pandya","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2021.08.065_bib22","first-page":"n135:1-7","article-title":"Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials","volume":"372","author":"Herrett","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jacc.2021.08.065_bib23","unstructured":"Agency for Healthcare Research and Quality. Medical Expenditure Panel Survey 2017. Accessed\u00a0October 8, 2021. http:\/\/meps.ahrq.gov\/mepsweb"},{"issue":"6","key":"10.1016\/j.jacc.2021.08.065_bib24","doi-asserted-by":"crossref","first-page":"452","DOI":"10.7326\/M15-0469","article-title":"Economic evaluation of combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task Force","volume":"163","author":"Li","year":"2015","journal-title":"Ann Intern Med"},{"issue":"21","key":"10.1016\/j.jacc.2021.08.065_bib25","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.jacc.2014.03.016","article-title":"ACC\/AHA statement on cost\/value methodology in clinical practice guidelines and performance measures","volume":"63","author":"Anderson","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacc.2021.08.065_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/M20-1392","article-title":"A\u00a0health opportunity cost threshold for cost-effectiveness analysis in the United States","volume":"174","author":"Vanness","year":"2021","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.jacc.2021.08.065_bib27","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/jama.2016.12195","article-title":"Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: Second Panel on Cost-Effectiveness in Health and Medicine","volume":"316","author":"Sanders","year":"2016","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.jacc.2021.08.065_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1161\/CIRCULATIONAHA.110.986349","article-title":"Cost-effectiveness of statin therapy for primary prevention in a low-cost statin era","volume":"124","author":"Lazar","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacc.2021.08.065_bib29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/hc0102.101774","article-title":"Antecedent blood pressure and risk of cardiovascular disease: the Framingham Heart Study","volume":"105","author":"Vasan","year":"2002","journal-title":"Circulation"},{"issue":"35","key":"10.1016\/j.jacc.2021.08.065_bib30","first-page":"697","article-title":"Prevalence of cholesterol screening and high blood cholesterol among adults\u2014United States, 2005, 2007, and 2009","volume":"61","author":"Fang","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"11","key":"10.1016\/j.jacc.2021.08.065_bib31","first-page":"1090","article-title":"Trends in lipid screening among adults in an integrated health care delivery system, 2009-2015","volume":"24","author":"Grant","year":"2018","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"6","key":"10.1016\/j.jacc.2021.08.065_bib32","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/CIRCULATIONAHA.105.548206","article-title":"Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age","volume":"113","author":"Lloyd-Jones","year":"2006","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.jacc.2021.08.065_bib33","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.gheart.2016.04.006","article-title":"Changes in serum cholesterol and diet in North Karelia and all Finland","volume":"11","author":"Vartiainen","year":"2016","journal-title":"Glob Heart"},{"issue":"8","key":"10.1016\/j.jacc.2021.08.065_bib34","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1037\/hea0000782","article-title":"Sound health care economics: provide the treatment needed (not less, not more)","volume":"38","author":"Spring","year":"2019","journal-title":"Health Psychol"},{"issue":"9","key":"10.1016\/j.jacc.2021.08.065_bib35","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/oby.22915","article-title":"A\u00a0factorial experiment to optimize remotely delivered behavioral treatment for obesity: results of the Opt-IN study","volume":"28","author":"Spring","year":"2020","journal-title":"Obesity"},{"issue":"11","key":"10.1016\/j.jacc.2021.08.065_bib36","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1161\/CIRCULATIONAHA.115.019014","article-title":"Long-term safety and efficacy of lowering low-density lipoprotein cholesterol with statin therapy","volume":"133","author":"Ford","year":"2016","journal-title":"Circulation"},{"issue":"10059","key":"10.1016\/j.jacc.2021.08.065_bib37","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.jacc.2021.08.065_bib38","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1056\/NEJMc2031173","article-title":"N-of-1 trial of a statin, placebo, or no treatment to assess side effects","volume":"383","author":"Wood","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.jacc.2021.08.065_bib39","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.11051","article-title":"Evaluation of aspirin and statin therapy use and adherence in patients with premature atherosclerotic cardiovascular disease","volume":"3","author":"Mahtta","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.jacc.2021.08.065_bib40","article-title":"Adherence to statin therapy among US adults between 2007 and 2014","volume":"8","author":"Colantonio","year":"2019","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2021.08.065_bib41","unstructured":"Centers for Medicare and Medicaid Services. License for Use of Current Procedural Terminology, Fourth Edition (CPT\u00ae). Accessed October 19, 2021. https:\/\/www.cms.gov\/apps\/physician-fee-schedule\/"},{"issue":"12","key":"10.1016\/j.jacc.2021.08.065_bib42","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/CIRCULATIONAHA.117.027067","article-title":"Evaluating the impact and cost-effectiveness of statin use guidelines for primary prevention of coronary heart disease and stroke.","volume":"136","author":"Heller","year":"2017","journal-title":"Circulation"}],"updated-by":[{"DOI":"10.1016\/j.jacc.2021.11.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:00:00Z","timestamp":1640044800000}}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721062756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109721062756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T17:23:16Z","timestamp":1778692996000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109721062756"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":42,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S0735109721062756"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2021.08.065","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cost-Effectiveness of Lipid-Lowering Treatments in Young Adults","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2021.08.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}